NL8900524A - Beenresorptie. - Google Patents

Beenresorptie. Download PDF

Info

Publication number
NL8900524A
NL8900524A NL8900524A NL8900524A NL8900524A NL 8900524 A NL8900524 A NL 8900524A NL 8900524 A NL8900524 A NL 8900524A NL 8900524 A NL8900524 A NL 8900524A NL 8900524 A NL8900524 A NL 8900524A
Authority
NL
Netherlands
Prior art keywords
leu
ala
glu
lys
ser
Prior art date
Application number
NL8900524A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888805231A external-priority patent/GB8805231D0/en
Priority claimed from GB888810899A external-priority patent/GB8810899D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8900524A publication Critical patent/NL8900524A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NL8900524A 1988-03-04 1989-03-03 Beenresorptie. NL8900524A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8805231 1988-03-04
GB888805231A GB8805231D0 (en) 1988-03-04 1988-03-04 Improvements in/relating to organic compounds
GB8810899 1988-05-09
GB888810899A GB8810899D0 (en) 1988-05-09 1988-05-09 Improvements in/relating to organic compounds

Publications (1)

Publication Number Publication Date
NL8900524A true NL8900524A (nl) 1989-10-02

Family

ID=26293587

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8900524A NL8900524A (nl) 1988-03-04 1989-03-03 Beenresorptie.

Country Status (17)

Country Link
EP (1) EP0331640A3 (fr)
JP (1) JPH01308234A (fr)
KR (1) KR890014124A (fr)
AU (1) AU621592B2 (fr)
BE (1) BE1003662A4 (fr)
CA (1) CA1332223C (fr)
CH (1) CH680070A5 (fr)
DE (1) DE3906923A1 (fr)
DK (1) DK102389A (fr)
FR (1) FR2628323B1 (fr)
GB (1) GB2216412B (fr)
HU (1) HUT52962A (fr)
IT (1) IT1230496B (fr)
NL (1) NL8900524A (fr)
PH (1) PH26238A (fr)
PT (1) PT89893A (fr)
SE (1) SE8900722L (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03197433A (ja) * 1989-12-26 1991-08-28 Otsuka Pharmaceut Co Ltd Ｉｌ―６産生誘導剤
IT1263022B (it) * 1992-11-06 1996-07-23 Angeletti P Ist Richerche Bio Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
GB9610281D0 (en) * 1996-05-16 1996-07-24 Ralston Stuart H Diagnostic method and apparatus
JP2001158736A (ja) * 1999-11-30 2001-06-12 Snow Brand Milk Prod Co Ltd 骨関節疾患の予防及び改善剤
FI112031B (fi) * 2002-02-25 2003-10-31 Valio Oy Biologisesti aktiivisen tuotteen uusi käyttö
WO2004064762A2 (fr) 2003-01-21 2004-08-05 S.S.C.I. Inc. Nouvelle co-cristallisation
ES2341461T5 (es) * 2004-02-11 2014-10-29 Warner-Lambert Company Llc Procedimientos de tratamiento de la artrosis con anticuerpos ANTI-IL-6
GB0912159D0 (en) * 2009-07-14 2009-08-26 Imp Innovations Ltd Methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE67035B1 (en) * 1986-07-08 1996-02-21 Genetics Inst Production and use of non-glycosylated IL-6
EP0585957A1 (fr) * 1986-08-06 1994-03-09 Ajinomoto Co., Inc. Facteur de différentiation des cellules B recombinant
US5271931A (en) * 1988-09-14 1993-12-21 The Scripps Research Institute Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6

Also Published As

Publication number Publication date
FR2628323B1 (fr) 1994-09-09
IT8947695A0 (it) 1989-03-01
DK102389A (da) 1989-09-05
DK102389D0 (da) 1989-03-02
EP0331640A3 (fr) 1991-03-13
AU621592B2 (en) 1992-03-19
DE3906923A1 (de) 1989-09-14
GB2216412B (en) 1991-10-02
EP0331640A2 (fr) 1989-09-06
PT89893A (pt) 1989-11-10
GB8904646D0 (en) 1989-04-12
CA1332223C (fr) 1994-10-04
BE1003662A4 (fr) 1992-05-19
JPH01308234A (ja) 1989-12-12
HUT52962A (en) 1990-09-28
KR890014124A (ko) 1989-10-21
GB2216412A (en) 1989-10-11
SE8900722D0 (sv) 1989-03-02
PH26238A (en) 1992-04-01
SE8900722L (sv) 1989-09-05
FR2628323A1 (fr) 1989-09-15
IT1230496B (it) 1991-10-24
CH680070A5 (fr) 1992-06-15
AU3094289A (en) 1989-09-07

Similar Documents

Publication Publication Date Title
Sabatini et al. Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice.
US7037892B2 (en) Hematopoietic stem cell proliferating agents
DE69526728T2 (de) VERWENDUNG VON IL-12 UND IL-12 ANTAGONISTEN zur Herstellung eines Arzneimittels FÜR BEHANDLUNG VON AUTOIMMUNKRANKHEITEN
JP2006306898A (ja) 二次性免疫不全症の治療法
KR920703819A (ko) 포유류 사이토긴, il-11
NL8900524A (nl) Beenresorptie.
EP0400762A1 (fr) Traitement d'animaux à l'aide d'IL-2, formulations à cet effet et leur préparation
DD298056A5 (de) Arzneimittel
JP2574962B2 (ja) 血小板減少症の処置方法及びそれに対し有用な医薬組成物
US5534251A (en) Stabilized il-1α medicinal composition
Russell et al. Humoral and local factors affecting bone formation and resorption
DE69224786T2 (de) Die Verwendung von Interleukin-6 zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Lymphocytic Leukemia und B-Zell Lymphoma.
EP0521916B1 (fr) Utilisation de l'il-4 pour stimuler la reponse immunitaire aux attaques d'antigenes infectieux
US5317012A (en) Human growth hormone induced improvement in depressed T4/T8 ratio
JP4414494B2 (ja) 白血球減少症の予防剤および治療剤
DE69117974T2 (de) Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen
EP0447353A1 (fr) Préparation pharmaceutique pour la maturation de prothymocytes
WO1998035696A1 (fr) Utilisation de thymosine alpha 1 pour la fabrication d'un medicament destine a favoriser le developpement de cellules souches
Phillips Regulation of cytokine production in the rat osteoblast by transforming growth factor-BETA
AU6028298A (en) Enhancement of hematopoietic cells
WO1998031385A9 (fr) Stimulation de cellules hematopoietiques

Legal Events

Date Code Title Description
BV The patent application has lapsed